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Objectives. Social support influences adherence to treatment in chronic illness, but
there is uncertainty about its facilitators and constraints. This study explored the forms,
processes, and responses associated with mobilization of informal support across three
life contexts amongst patients with Xeroderma Pigmentosum (XP), a condition requiring
rigorous photoprotection to reduce cancer risks.
Design. Qualitative interview study.
Methods. A total of 25 adults with XP participated in semi-structured interviews
conducted face to face. An inductive thematic analysis was applied using a framework
approach.
Results. Practical support, involving both assistance with recommended photoprotec-
tion and adjusting daily activities to reduce exposure, was the key form of support
provided by family and friends. However, responses to this support differed with two
groups identified based on the relative priority given to photoprotection in daily life and
processes of disclosure. For ‘positive responders’, support aligned with their own
priorities to photoprotect, conveyed feelings of being cared-for and was facilitated by
talking openly. In contrast, for ‘negative responders’ support conflictedwith their priority
of living ‘normally’ and their limited disclosure hindered receipt of helpful support in
personal, clinic, andwork interactions. Fears of workplace stigma also reduced disclosure
amongst participants open in other contexts.
Conclusions. Practical support conveyed psychosocial support with positive effects
on adherence. This suggests the traditional separation into practical and emotional
support is overly simplistic, with measures potentially missing important aspects.
Interactional processes contribute to the effects of support, which can be addressed
by targeting disclosure, stigma, and other barriers at individual and organizational
levels.
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reproduction in any medium, provided the original work is properly cited.
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What is already known on this subject?
 Social support can be both a facilitator and a hindrance to treatment adherence.
 Practical support is identified as the most important form of support in the context of adherence.
 The processes of support underpinning its relationship to adherence are unclear.
What does this study add? Variations in the provision and impacts of support are influenced by participants’ disclosure and
attitudes to photoprotection, with two key groups comprising ‘positive responders’ and ‘negative
responders’.
 The influence of emotional support on adherence may be underestimated through neglect of the
ways in which practical support often conveys feelings of being valued and cared-for.
 Barriers to mobilizing effective adherence support extends across life spheres, with fears of stigma
and discrimination in work settings highlighting the need to intervene at individual and
organizational levels.
Poor adherence to treatment is a continuing barrier to optimal health care outcomes,with
estimates indicating that up to 50% of medications prescribed to people with long-term
conditions (LTCs) are not taken as prescribed (WHO, 2003). Rates of adherence for
recommended behavioural changes (e.g., diet, physical activity, photoprotection) are
even lower (Khan & Socha-Dietrich, 2018). Adherence studies have reported moderately
positive correlations between instrumental or practical support (behavioural or material
assistance with tasks) and adherence, with weaker associations for emotional support
[demonstrations of love, caring, sympathy (Thoits, 2011)] (DiMatteo, 2004; Scheurer,
Choudhry, Swanton, Matlin, & Shrank, 2012). However, despite these associations we
know little about ‘how’ support may influence adherence. Psychological models
employed to understand adherence, such as the Common-Sense Model of illness
(Leventhal, Meyer, &Nerenz, 1980) and the Health Action Process Approach (Schwarzer,
2008), acknowledge the importance of social influence but the processes involved have
not been examined. Responding to this gap, condition-specific reviews of support and
adherence (Ladin, Daniels, Osani, & Bannuru, 2018; Miller & DiMatteo, 2013) and the
wider support literature recommend that qualitative research is required to focus on the
mechanisms leading to the observed associations between support and adherence
(Thoits, 1995, 2011; Vassilev et al., 2011).
As part of a programme of mixed-methods research to improve adherence to
photoprotection amongst people with Xeroderma Pigmentosum (XP; see Walburn et al.,
2017), a very rare genetic condition,we identified gaps in theunderstanding of the influence
of social processes on adherence. Patients with XP are required to constantly follow an
extremely demanding photoprotection regime because they are unable to repair DNA
damage to the skin caused by exposure to ultraviolet radiation (UVR) in daylight (Sethi,
Lehmann,&Fassihi, 2013). This involveswearing a transparent face visor or other protective
head/face covering, UVR protective clothing, glasses, and regular use of a broad-spectrum
sunscreen, together with reducing time spent outside and exposure to daylight (Fassihi,
2013). Although following this regime is theonlyway to avoid thepotentially life-threatening
skin and eye cancers (Bradford et al., 2011), adherence can be poor (Walburn et al., 2019).
As little is known about social influences on photoprotection, there is a need for a rich
contextual understanding of how social support might ‘work’ in people’s daily lives to
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inform an effective intervention. We selected a qualitative approach, which is ideally
suited to studying under-researched topics, and can provide explanations as to ‘how’ a
phenomenon operates (Green&Thorogood, 2004). This study of adultswithXP explored
the role of support in adherence to photoprotection by investigating support interactions
from the perspective of the recipient. It focused on the forms of support provided, the
influence of patient–supporter interactions and responses to support. The study also
examined supportive relationships provided not only by family and friends, but also
encountered in the spheres of work and the XP clinic.
Methods
Design
A qualitative study with individual semi-structured interviews conducted with adults
diagnosed with XP. The study was approved by Camden & Kings Cross Research Ethics
Committee 15/LO/1395, London, UK.
Recruitment process
Patientswere eligible to participate if theywere diagnosedwithXP and received their care
from the UK’s only XP specialist multidisciplinary service at Guy’s and St Thomas’ NHS
Foundation Trust. Patients included were aged 16 years and over, were not cognitively
impaired, spoke English adequately to take part in an interview, and had not opted out of
taking part in any research. Eligible adults (n = 38) were identified by a consultant
dermatologist from the clinic register and sent an information sheet with a covering letter
detailing the aims of the study and how to contact the study team. After two weeks,
patientswere phoned by a research nurse to askwhether theywould like to take part or, if
due to attend the clinic, theywere approachedduring their routine appointment. Twenty-
five patients decided to participate. Of those who did not take part, seven could not be
contacted and six declined to participate (4 men and 2 women), explaining that they did
not have enough time or did not want to think about XP.
Characteristics of participants
We interviewed 17 male and 8 female participants aged between 16 and 63 years from a
variety of ethnic groups. Of these, 13 had Asian backgrounds, which reflected the higher
prevalence of XP in communities from theMiddle East (Fassihi, 2013). The gender balance
was indicative of the higher proportion of adultmale patients registeredwith theXP clinic
(26 men and 17 women). Thirteen were married or living with a partner. The sample was
diagnosed with a range of XP genetic complementation types, and 11 participants had
experienced skin cancer. To protect anonymity, we do not report the characteristics of
each participant and new study numbers were allocated.
Procedure and materials
All interviews were carried out between February and June 2016. All were conducted in
patients’ homes, except for a single telephone interview due to the participant being
abroad. Two non-medical researchers (RA/JW), experienced in qualitative interviewing,
separately conducted the interviews and were accompanied on the home visit by a
research nurse. The researchers and nurse were not known to the participants. Written
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informed consent was obtained by the nurse, whowas not present for the interview. The
interviews lasted for about an hour andwere steered by a topic guide designed to elicit the
range of experiences associated with living with XP, managing the required photopro-
tection and their experiences of social support (see Table 1). Interviews opened with
broad ‘leading-in’ questions designed to start to focus attention towards the potential
challenges of living with XP, followed by narrower more specific topics with prompts as
required. The topic guide provided a flexible framework to structure the discussion, but
the direction of the interview was led by the participant.
Analysis
Interviews were recorded with permission and transcribed verbatim by an independent
transcribing agency. Anonymity was maintained by referring to the participant ID at the
start of the recording. Transcripts were checked for accuracy with recordings by RA and
then initially read and re-read by all team members (RA/MM/JW). Analysis was inductive
and based on a framework approach (Ritchie&Lewis, 2006). Transcriptswere coded, and
data were entered into NVivo 11 software. The main themes were then identified and
summarized in a matrix, with cases as rows and themes as columns. This approach
facilitates a constant comparativemethod as participants’ responses to a single theme can
be viewed in the context ofmultiple themes, leading to the development of typologies and
explanatory accounts (Gale, Heath, Cameron, Rashid & Redwood, 2013). Initially, team
discussions were held to develop and refine emerging themes, which were then applied
to the whole dataset by RA and reapplied by MM/JW as a check. Saturation of themes was
achieved after eighteen cases. Next, detailed further refinement of themes took place
(e.g., forms of support for photoprotection provided by family and friends) and
subthemes identified (e.g., assistance for photoprotection practices before or during
outdoor time). This further process of constant comparison culminated in the
identification of a pattern of responses to social support common to two groups of
participants, those who responded ‘positively’ or ‘negatively’. Further analysis of positive
and negative responders was then undertaken to compare their experiences of support,
interactions across contexts, and photoprotection activities. The analysis moved beyond
description to generate explanatory interpretive accounts of the processes underpinning
these responses. Mapping was used to facilitate the testing of hypotheses (e.g., How is
disclosure linked to response to support provided by colleagues?) and to explore
relationships between phenomena. Analysis was dynamic, moving back and forth from
description to mapping.
Table 1. Excerpt from the topic guide for participants with XP
Weknow from talking to other peoplewithXP that friends and family can helpwith photoprotection – do
they help you or not?
How do they help? What do they do? Is there anything that they do that you don’t find helpful?
What sort of help do you get? Is it directly related to XP or more general support?
Is it enough to know that support is there if you need it?
Are there times when friends or family don’t help and make photoprotection more difficult?
How helpful have you found going to the XP clinic? In what way? (explore clinical management of XP/role of
clinic/other forms of support)
Do different people give different sorts of support? (explore sources of support, family, friends, work
colleagues)
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The credibility of the analysiswas supported by regular group review. For example, JW
first categorized the participants as positive or negative responders and then justified
groupings in response to questions and analysis by RA and MM. Any uncertainty about
groupmembership initiated further discussion, a return to the data and continued review
until an agreement was reached. A reflective diary was also kept during the analysis to
keep concepts grounded in the data.
The credibility of the categorization of responses that emerged from the initial
stages of analysis was assessed through a group discussion held with the two Clinical
Nurse Specialists (CNS) from the XP clinical team. The CNS volunteered to take part.
They were female, aged between 35 and 55, and have both worked with XP patients
for over 5 years. We aimed to ascertain whether they recognized positive and negative
responders from their clinical experience. This discussion provided additional insight
into how, from the perspective of the HCP, the nature of responses to social support
influenced support interactions at the clinic. We then returned to the data to consider
whether there were differences in how negative and positive responders viewed the
clinical interaction, which further informed our explanatory accounts. We gained
written permission from the CNS to record the discussion and include quotations in
the findings.
The findings and interpretation were also discussed with the Patient and Public
Involvement (PPI) panel. Four PPI representatives (one patient, two parents, one teacher)
participated in a discussion session. JW presented the forms of support with the different
responses, and the group considered how the findings corresponded to their own
experiences.
The Standards for the Reporting of Qualitative Research Guidelines (SRQR; O’Brien,
Harris, Beckman, Reed, & Cook, 2014) were adhered to (see Table S1).
Results
The initial focus is on the experiences of the forms of support provided by family and
friends, which are inherently positive. This is followed by an in-depth analysis and
explanatory account of processes underpinning responses to support, which included
both positive and negative reactions (see Figure 1). We then examine social support
responses within the wider social contexts of the XP clinic and work environments.
Forms of support for photoprotection provided by family and friends
Assistance for photoprotection practices before or during outdoor time
Most participants spoke of photoprotection-specific support being routinely offered by
both friends and family. Practical support involved assisting directlywith photoprotection
tasks, such as giving reminders about applying sunscreen and wearing protective
clothing.
They’re always reminding me, have you got your sunblock on, have you got your glasses?
(no.1, female, 45 years).
Friends and family also monitored UVR risk ‘in the moment’, alerting patients to
perceived danger and moving into shade if there was none:
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If I’ve been in the shade and then suddenly, I walk through a sunny patch. Everyone will say
quick, over here, and we’ll swap places (no.16, female, 63 years).
They’re all quite fussy. . .[about shade] and they’ll dig umbrellas out for me (no.23, male, 55
years).
Others described family members negotiating with strangers to enhance protection in
public situations.
someonewas leaning on the blind and it was staying up, and she just grabbed it and dragged it
down. . .. . .She said my brother needs this down (no.22, male, 26 years).
Adjustment of daily activities
Close family often reduced UVR risk through altering daily activities, including shifting
activities to the evening and engaging in new roles such as taking on responsibility for
outdoor chores or errands. As one man explained:
if we are going shopping during the day, then I’m the one who would normally be staying in
the car. . .. . .and the missus would actually go into the shops (no.10, male, 39 years).





































Figure 1. Themes, sub-themes, and explanatory accounts underpinning responses to support provided
by family and friends. [Colour figure can be viewed at wileyonlinelibrary.com]
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People of all age groups described how friends would adapt daily activities to take
account of their need to avoid UVR, including shifting social activities to different times of
day or allowing extra time to apply protection. These adjustments facilitated better
photoprotection and respondents appreciated that this was generally done subtly, with
the minimum of fuss.
they just brush it off, like yeah that’s fine. As long as you’re safe,we’re happy to chill out and let
you put it on (no.19, male, 18 years).
Feeling valued and emotionally supported
Feelings of supportwere described as bolstering individuals’ emotional state and confidence
to photoprotect, helping to reduce the negative impacts of living with such a demanding
regime. Participants rarely spoke directly about emotional support, although several
explained that they felt ‘cared-for’ by the adjustment of activities and photoprotection-
specific support. A teenager described how he felt about the reminders from his family:
It is helpful, and it just shows that they care, that’s it. (no.11, male, 16 years).
For younger participants, adjustments conveyed acceptance and contributed to
participants feeling valued by their social circle:
Things they are organising, like dinners for their birthdays. It’s like right, we’ll go out at 9pm
and then you can. It’s not like oh, then you can come. It’s like we’ll go at this time. They don’t
need to say why or. . . I think that’s just good friends (no.22, male, 26 years).
When ‘direct’ emotional support was needed, it was sought from a select few with
whom they felt most comfortable. Some participants explained that knowing help was
available was enough to feel emotionally supported:
I have to say that’s a very important type of support for me to know that, that their help. . . I
probably don’t use it much, but it’s really good to know that there’s someone I can talk to if I
need to. (no.9, male, 38 years).
Interactions: Processes and responses
Positive responders
Eighteen people across the age span (16–63 years) were categorized as ‘positive
responders’. These participants spoke positively about the support from family and
friends. They appreciated the practical assistance with its positive emotional ‘side-effect’
of ‘feeling cared-for’. This support enabled participants to better adhere to photoprotec-
tion and reduce daily UVR exposure.
Yeah, it’s good to have someone reminding you. It’s good to have the reminder there. Because
you’re reminded, I don’t go outside unprotected and be at risk (no.17, female, 62 years).
Similarly, another woman talked about the support provided by her daughter:
if my daughter is around, if I’m around her, they do. Like now, go put your sunscreen on and
whatever. . .. . .. . . Yeah, it is helpful (no.25, female, 55 years).
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Practical assistance was gratefully received, since it aligned with the recipient’s
emphasis on the importance of photoprotection. Positive responders were aware of the
risks of UVR and were convinced that photoprotection was necessary. As a younger man
described:
Even on cloudy days it’s still harmful for us. . . I’m always clothed up, hooded up, sun cream,
I’ve got over like 100 SPF on my face and then got my cap (no.7, male, 27 years).
Positive responders’ support from friends was facilitated by their own willingness to
freely disclose their condition and photoprotection needs.
I tell everything. . ..like how every year I go to London to see the whole specialist team. . ..tell
them about mywindow being protected. I tell them howmy life has been affected because of
XP (no.11, male, 16 years).
Those who had been living with the condition for many years explained that friends
and family knew all about their photoprotection needs:
So I thinkmost people know about it. Yeah, when I’m talking about it or in conversation I say
oh, I’ve got to put onmy, findmy glasses. I’ve got to do this, put, you know,most ofmy friends
know that’s my regime, or what’s going on. . .. . . (no.16, female, 63 years).
Newly diagnosed positive responders wanted others to understand the rationale
behind their photoprotection activities: As one participant explained:
. . .generally if I go out with my friends, and I’ve said to them I want to be in the shade.
. . .. . .I’ve always said to them that it’s just because ofmy skin condition and I need to be in the
shade, whereas my skin doesn’t, can’t repair myself as quick as, well, as you guys can. . . it’s
DNAwhere my skin tends to basically not repair certain things, whereas . . .you can go out in
the sun and not worry. . . (no.4, male, 36 years)
The degree of openness varied. Some initiated conversation about XP, whereas most
responded to questions about their photoprotection behaviour.
I look very differentwith the visor on so it’s not surprising that peoplewant to knowwhy. So if
someone wants to ask a question . . .I don’t mind answering (no. 13, male, 28 years).
Negative responders
Six younger participantswere categorized as ‘negative responders’. This group comprised
fourmen and twowomen, aged 20–37 years, ofwhich four experienced a severe burning
response to UVR. In contrast to the positive responders, they were reluctant to talk about
their condition, did not find practical support helpful, and did not feel emotionally
supported.
For these participants, reminders from both friends and family were annoying and
inappropriate. They drew unwanted attention to a feeling of difference that
participants wished to conceal. These reminders conflicted with their approach to
living with XP, which was characterized by prioritizing being ‘normal’ over and above
photoprotection.
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I just think it’s a constant reminder that I’m different. So that’s why I don’t really like them
[reminders to wear jacket when going out] (no.12, male, 21 years).
Theywere also internally conflicted about the need to protect; although aware of risks
of UVR, they were reluctant to undertake photoprotection. As a younger participant
explained:
There are times. Like usually it happens, I just think whatever. I just go out (without
protection). . . I know it’s bad,. . . (no.12, male, 21 years old).
In contrast to positive responders, they experienced strong feelings of difference
associated with the visible damage to the skin from UVR and ‘standing-out’ when
photoprotecting:
My arms are full of freckles and my chest as well. . . I just want to be normal. . .You know,
blemishes (freckles).Why am I so different? I look odd. I just look odd (no. 2, female, 35 years)
It’s like weird, I’m the weird person because I’d suddenly disappear because I can’t walk
across the road (expose self to UVR) to buy stuff they’re buying. (no.15, male, 34 years).
Not talking much about XP to friends was a further defining characteristic of the
negative responders. Theywould not explain their condition to friends as this respondent
explained:
I’m not really good at talking, I just tell them it is a skin condition. . .I didn’t ask for it, it just
happened. They don’t need to know (no.6, male, 20 years).
This group feared that being open would result in others thinking more negatively
of them and would mean they had to deal with more questions and inappropriate
comments. By limiting disclosure, these participants felt they were able to preserve
their ‘normality’.
In a way it [not telling others] actually helps because then I’m just seen as normal rather than,
oh you have to stay away kind of thing (no.12, male, 21 years).
Some explained that being secretive about XP had been encouraged by family
members.
My dadwas, no, don’t tell anybody about it. None of his family. . .Nobody knew (no.15, male,
34 years).
This group also spoke of instanceswhere family and friends, whowere not fully aware
of their condition, actively encouraged them to take greater risks with UVR. Individuals
were also sometimesmockedwhen they did useprotection (e.g., application of sunscreen
as effeminate). One patient described friends encouraging him not to wear protective
clothing that would attract negative comments:
I put my hoody on but it looks strange and people say. . .Take that off, you’re making us look
very dodgy and blah-di-blah (no.3, male, 37 years).
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Others discouraged the use of the UVR metre, which is recommended to check UVR
levels in new environments,
like if I was in the car with my sister, she would be like put it (UV meter) away, you’re
going to keep going on about it. We’ve come out to relax and to be free (no.18, female,
31 years).
Some, particularly those who had not experienced skin cancer, felt that other friends
or acquaintances did not view XP as a serious medical condition. They did not feel
supported by their friends and men described a lack of empathy from their peer group.
I think it’s people’s lack of understanding. It’s such a non-obvious, it’s such a subtle problem,
right? If I have no leg, okay, people would see. Oh, yeah, just wear sun block, blah-blah-blah
(no.15, male, 34 years).
Mainly it’s themen, they say oh you’re aman. . .dealwith it you’ll be fine (no.3,male, 37 years).
Descriptions of feeling emotionally supportedwere notable by their absence.Negative
responders described feeling isolated. As a younger man explained in response the
following question:
Do you have any close friends that you feel understand XP? (Interviewer)
Not really. I’m an outsider. I don’t have that many friends anymore (no.6, male, 20 years).
The forms of support provided by family and friends, and explanatory processes
underpinning responses are summarized in Figure 1. This illustrates the different levels of
the support process and highlights the importance of the interactions between the
recipient and the provider in shaping responses. Open disclosure and shared priorities
were instrumental in facilitating a positive response to support that is offered, whereas
concealment and mismatch of priorities left patients feeling isolated and unsupported.
Hence, in contrast to negative responders, positive responders benefited from a broader
range of support.
Wider supportive relationships
Clinical staff at the XP service
Nearly all participants commented very favourably about the specialist XP clinic in terms
of the information provided about XP and types of protection, given during their routine
clinical appointment. However, there were differences in how positive and negative
responders interactedwith the staff,which influenced the quality of their relationship and
the support they received. Positive responders described a proactive and collaborative
relationship between themselves and the medical team, which extended the perception
of support beyondwhat was received during the routine appointment (annual/biannual).
They felt supported between appointments because they could contact staff if needed. As
a participant who had been diagnosed nine years ago explained:
So if I’ve got problems with my skin condition, I just, I can email my nurse and she’ll help.
(no.19, male, 18 years).
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They actively sought assistance, freely disclosed, and welcomed staff following up
their photoprotection resolutions made during appointments. As one participant
explained in relation to the specialist nurse:
Makesmedo things that Iwouldn’t do. Callmeon thephone andhave youdone that, have you
done this? I never thought about window film, she said it’s important you do that. (no.21,
male, 62 years)
As the nurses were aware of the patient’s life circumstances, they would go to great
lengths to fit clinical care around the individual. Staff would facilitate photoprotection at
work by helping to ensure that the environment was UVR safe and educating patient’s
colleagues.
You wouldn’t phone that patient on that day, as that’s when they work (CNS B).
we assessed a whole university and worked out (using a UVR meter) where there was a safe
area in each lecture room (CNS A).
Furthermore, if they knew of deficits in a patient’s informal support system, they
would try to plug the gap.
I know that some patients don’t have the support network around them, so I’ll drop them an
email or text to say good luck for your surgery, how did it go?. (CNS A)
In common with the practical support provided by family and friends, these forms of
support contributed to patients’ feeling that they were cared-for.
In contrast, the negative responderswere not active partners in themanagement of XP
and were not able to take advantage of the enhanced support available from the clinical
team because they did not proactively disclose their needs. As one of the specialist nurses
explained, certain patients did not actively engage; they limited contact and opportunity
for support to the single appointment:
Somepeople just come to clinic and that is the only time they haveXP. Even if you reach out to
them during the year, you get nothing back. (CNS A)
Prioritization of ‘normality’ above XP requirements was a barrier tomaking best use of
that routine clinic appointment, as a younger man admitted:
You just think I don’t want to be here, I want to get on with my life. Even though the doctors
and everything are so nice, you don’t want to see them. (no.12, male, 21 years)
Colleagues at work
There were some examples of employers supporting patients to photoprotect at work.
For example, one participant who was a teacher explained:
I also have to say the school, they timetable my classes in rooms that don’t get any sunlight so
that’s helpful (no.9, male, 38 years).
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However, several positive and negative responders explained that they actively
concealed XP from those they worked with; they feared a negative reaction that might
impact on opportunities at work and alter colleagues’ perceptions about what they were
able to do. Fears of disclosure and subsequent lack of support were felt most keenly by
negative responders, but some positive responders also described concerns about what
others might think:
None of my colleagues know ofmy condition. Mymanagement do, but not people I see every
day. I’m there putting my cream on and they [would be] giving me the funny looks. (no.10,
male, 39 years).
He admitted that sometimes this stops him protecting.
People whowere openwith family and friends were also oftenmore guarded at work.
For example, an older office worker made light of his photoprotection needs:
you don’t want to be separate from the team, as such. You want to just be part of the normal
everydayworking life, as it were. . .. when they ask I say I find the sun a bit too strong and they
just take it. (no.8, male, 63 years).
Someparticipants also feared an emotional over-reaction,whichwould require further
unwanted elaboration.
I had to go to make an appointment with my manager to say right, I’ve got to go through this
treatment. And she started crying. Yeah, and she’s like I don’t want you to die. (no.24, female,
28 years).
Disclosure occurred only if essential, for example, requiring time off work for
treatment. Little support was available for daily photoprotection needs and individuals
generally managed UVR risk by altering their own behaviour.
So as soon as I come in they’ve got the blinds all up and I will put the blinds downwhen I get
there. (no. 18, female, 31 years)
I always make sure my back is to the windows type of thing (no.2, female, 35 years).
Credibility checks
The forms of support provided by family and friends were recognized by the parent and
patient members of the PPI panel. No new aspects of support activities arose during
discussions. Teamdiscussions about initial groupings supported the existence of different
support responses. Classification of participants as positive or negative responders was
clear-cut because the negative responders consistently described poor support experi-
ences across different contexts. As expected, there was some within-category variation,
related specifically to the limiting of disclosure at work for some positive responders. The
categorization of participants was endorsed by the clinical team.
Discussion
This study draws attention to the variety of ways support is provided to participants with
XP, alongside implications for photoprotection. Such support conveyed feelings of being
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cared-for, which was important for many patients in coping with photoprotection
behaviours that marked them out as different (Anderson, Walburn, & Morgan, 2017). The
experience of emotional benefits from ostensibly practical photoprotection support
highlights shortcomingsof theubiquitous separationof social support intodistinct practical
and emotional categories. Our findings indicate that it should not be assumed that practical
support solely benefits adherence in terms of the enactment of the health behaviour (i.e.,
photoprotection). There is no consensus aboutwhat constitutes emotional support and the
subtleties of how it is conveyed have rarely been researched (Kowitt et al., 2015). It is
hypothesized that conclusions about the stronger relationship between practical support
and adherence, reported by quantitative studies (DiMatteo, 2004), haveunderestimated the
role of emotional support. By using measures which focus on the provision of overt
emotional support [e.g., The Social Support Inventory (Timmerman, Emanuels-Zuurveen,&
Emmelkamp, 2000); Significant Others Scale (Power, Champion, & Aris, 1988], they have
missed the nuances of the experience of emotional support.
The study also highlighted (in terms of disclosure of XP and responses to the support
offered) the importance of interactions between the support giver and receiver. These
processes had important implications for photoprotection. Five out of six participants
identified as negative responders in this analysis corresponded to those identified as
strongly resistant to the photoprotection regimen with the lowest level of adherence in a
prior qualitative analysis (see Morgan et al., 2019 for details of responses to photopro-
tection). The response to support depended on the extent to which both parties had
shared values and priorities. Where support conflicted with the patient’s model of XP
(e.g., where the patient prioritized normality and the provider emphasized UVR risk),
supportwas rejected. Overt encouragement not to protect could also be linked to conflict
between the patient’s medical model of XP and the ‘minor condition model’ of the peer
group. Differences in perceptions of LTCs between patients and close relatives, or
significant others, have been found to have deleterious effects in other conditions which
require multiple self-care behaviours (Pereira, Pedras, Machado, & Ferreira, 2016; Searle,
Norman, Thompson, & Vedhara, 2007). Our findings reiterate early work by Revenson,
Schiaffino, Majerovitz, and Gibofsky (1991) highlighting the existence of ‘problematic
social support’ and contribute to understanding why a negative social environment is
especially toxic (Helgeson & Zajdel, 2017). In this context, unhelpful practical support
does not improve photoprotection; as a negative social interaction, it is also associated
with greater distress (Wijnberg-Williams, Kamps, Klip, & Hoekstra-Weebers, 2006). This
has been shown to independently hinder adherence (Kardas, Lewek, & Matyjaszczyk,
2013). We therefore speculate that negative social processes, by limiting social resources
and amplifying the influence of other barriers, directly and indirectly impact adherence.
We have identified that disclosure is a prerequisite for accessing support, as depicted in
models such as The Disclosure Process Model (Chaudoir & Fisher, 2010), and is also an
ongoingmechanismbywhich support is tailored to be helpful.Without disclosure atwork,
there was little opportunity for helpful support. Even if personal and clinic support were
still to be provided, without further disclosure or discussion, this would be unlikely to
match the needs of the patient (cf. Cutrona&Russell, 1990).We speculate that an outcome
of the disclosure process is an increased personalization of support. In terms of clinical care
– by requesting support for issues that are most relevant, the engaged individual is
benefiting from amore personalized conditionmanagement. This, in turn, is expected to be
associated with better outcomes in adherence interventions (Allemann et al., 2017).
Informed by the literature that disclosure itself reduces stigma by emotional processing
(Beals, Peplau, & Gable, 2009), it is speculated that disclosure may improve adherence to
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photoprotection in twoways; it facilitates the receipt of helpful support (as above) and also
diminishes feelings of shame (Clarke, Thompson, Jenkinson, Rumsey, & Newell, 2013),
which is an additional internal barrier to adherence (Morgan et al., 2019). However, there is
an important caveat.Disclosure is onlybeneficialwhen the response ispositive (Chaudoir&
Fisher, 2010). In thework context, being openmay have real personal costs in terms of loss
of status, job roles, and even employment (Beatty, 2012). Fears of such outcomes are
widespread in stigmatized conditions such as HIV (Cama, Brener, Slavin, & de Wit, 2017)
and mental illness (Bos, Kanner, Muris, Janssen, & Mayer, 2009). This validates the work of
the clinical team to educate and communicate accurate information about XP to employers
in occupational settings. Reviews of the work environment emphasize the role organiza-
tions have in developing a ‘disclosure or stigma-friendly culture’; it is not only behaviour
change at the individual level that is required (Szeto & Dobson, 2010).
Strengths and limitations
This study fills an important gap in the conceptual understanding of how social support
influences adherence. This is especially important in the context of a disease where
research has previously focused on biological, rather than psychosocial, influences on
outcomes. We provide an in-depth exploration which moves beyond description to
explain phenomena. The trustworthiness of the reported positive and negative responses
to support is significantly enhanced by the credibility checks, involving the XP clinical
team and the PPI panel. However, the research context of the study and the rarity of XP
constrainedour approach. Given the demands of thewider programmeofmixed-methods
research (Walburn et al., 2017), we were limited to a single interview. We therefore
focused on participants’ current experiences and did not examine how responses to
social support may have changed over time with altered life circumstances and
developments in the patient’s clinical condition. Future qualitative studies should
explore responses to support amongst newly diagnosed XP patients. They should also
examine patterns of responses to support during stressful periods, when explicit
emotional support may be more important. Given that XP is a very rare condition and
participantswere taking part in a demandingmixed-methods programmeof research, due
to fears of participant burden, it was also not feasible to undertake respondent validation.
Implications
We identified a sub-group of patients who do not experience helpful support from their
family and friends, do not access it atwork, and donot benefit fully fromhelp available from
their health care professionals (HCPs). We consider that these findings can inform
intervention at the individual level to improve adherence to photoprotection in XP in the
United Kingdom. To mobilize support, self-management programmes need to raise the
individual’s awareness of ‘support opportunities’, by encouraging self-assessment of
current support gaps and identifying ways in which others could assist with daily
photoprotection requirements. For support to be a facilitator of adherence, barriers to
perceiving it as helpful (i.e., enabling a positive response) should also be targeted. Negative
responders would benefit from therapeutic strategies, such as linking life values with
desired behaviour (i.e., better photoprotection; Zhang et al., 2018), to reduce feelings of
difference and promote acceptance. Exploration of the pros and cons of an individual’s
current use of their network could be discussed, in conjunction with their willingness to
disclose. Costs to the individual need to be fully considered, as a positive response to
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disclosure cannot always be assumed. Development of communication skills (e.g., active
listening)wouldbebeneficial.Whilst these recommendationsmaybe relevant for globalXP
populations, further research is advised in non-Western XP populations with different
cultural contexts and health systems. Notwithstanding that experiences of support in XP
are likely to have parallels with other photosensitive conditions, the extreme level of
protection required suggests that the nature and pattern of responses could be different
when less rigorous photoprotection is prescribed.
Beyond the individual, changes in the clinical and work environments are required.
Clinicians already encourage significant others (family/friends) to be present at
consultations. Based on findings that illness perceptions are modifiable (Jones, Smith, &
Llewellyn, 2015), we recommend that HCPs also explore discrepancies and misunder-
standings about XP and photoprotection. Incorporation of stigma-reducing programmes
at the occupational and societal levels, for example, campaigns promoting acceptance of
staff with mental and physical health conditions (‘This is me’-Barclays, n.d.) and visible
difference initiatives (Changing Faces, n.d.), help tominimize environmental barriers that
play a part in the poor mobilization of helpful support by the individual.
Conclusions
By identifying modifiable processes and interactions that explain why social support can
be both an enabler and obstacle to photoprotection, we confirmed the importance of
moving from a narrowly patient-focused approach to adherence in LTCs, to a more
socially contextualized approach.
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